Abordaje terapéutico en las forunculosis recidivantes. Consulta de inmunología. Pinar del Río

a two- stages study was conducted: the first included the cases and controls, analytical and cross-sectional; and the second stage with a longitudinal and prospective intervention in patients suffering from relapsing furunculosis. the target group was comprised of patients under 20 years old attending to immunology clinic during 2006-2010; the sample, 89 patients with furunculosis who agreed to participate in the study, and a control group of 182 patients with mild respiratory symptoms. age, gender, skin colour, immunoglobulin levels and nasopharyngeal smear in those presenting coexistence were the variables analyzed. a treatment in three groups was followed: one (1) only with specific antibiotic therapy for furunculosis, besides a second group followed the treatment of those with coexistence, and a third one, with the approach of the second group receiving immunomodulators. results showed furunculosis in association with children of older ages and white skin, besides a very significant statistical association with at least, one of them, showing coexistence with a positive smear of staphylococcus aureus (s. aureus) and the possibility to develop relapsing furunculosis. combined-specific antibiotics are required, as well as the use of the therapeutic approach of those presenting coexistence and immunomodulators to achieve a successful treatment.